Last Week in GER Research: Meituan-Dianping, Nio, Gangfeng Lithium, Pinduoduo and 111 Inc
Below is a recap of the key IPO and fundamental research produced by the Global Equity Research team. This week we highlight a more palatable...
333 Views
NIO IPO: August Metrics Point to Potential Signs of Waning Consumer Interest
In an F-1/A filing, NIO Inc (NIO US) published the number of reservations and vehicles produced and delivered for the month of...
322 Views
ECM Weekly (1 September 2018) - Meituan, NIO, Aavas, Hua Medicine, Qutoutiao
Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...
427 Views
NIO (蔚来) IPO Review - Blue Sky Assumptions Value It at Just a Small Discount to Peers
NIO Inc (NIO US) is raising up to US$1.3bn in its upcoming IPO and proceeds raised will be mainly used for R&D and capital expenditure. We have...
490 Views
Nio IPO (Part 2- Valuation): The Issue Looks Reasonably Priced
In our earlier report, we covered NIO Inc (NIO US)’s background, its business model, the growth prospects and risks it faces in the market. We...
531 Views